|
|
||||||||
Department of Thoracic and Cardiovascular Surgery, St Vincent Hospital, Indianapolis, Indiana
Accepted for publication March 25, 2009.
* Address correspondence to Dr Freeman, 8433 Harcourt Rd, Indianapolis, IN 46260 (Email: rfreeman{at}corvascmds.com).
Presented at the Fifty-fifth Annual Meeting of the Southern Thoracic Surgical Association, Austin, TX, Nov 5–8, 2008.
| Abstract |
|---|
|
|
|---|
Methods: A retrospective analysis of patients undergoing RS for palmar hyperhidrosis was conducted. Comparison was made with all patients undergoing an initial thoracoscopic sympathectomy (TS) for palmar hyperhidrosis at our institution during the same period.
Results: Over 6 years, 40 patients underwent bilateral (32) or unilateral (8) RS for refractory (35) or recurrent (5) palmar hyperhidrosis. During the same period, 321 patients underwent bilateral TS for palmar hyperhidrosis. Previous methods of sympathectomy included percutaneous ablation (25), TS (10), axillary thoracotomy (3), and a posterior transthoracic approach (2). Twenty-two RS patients and 11 TS patients required a third port to complete the procedure because of pleural adhesions (p = 0.0001). Twenty-three RS and 11 TS patients required postoperative pleural drainage (p = 0.0004). Mean length of stay was1.6 for the RS group and less than 1 day for the TS group (p = 0.0001). Alleviation of palmar hyperhidrosis occurred in 38 RS patients and 316 TS patients (p = 0.18). Compensatory sweating was identified in 21 RS patients and 101 TS patients (p = 0.01).
Conclusions: Reoperative thoracoscopic sympathectomy produced a rate of improvement comparable to that of TS. However, RS was associated with an increased need for postoperative pleural drainage, longer hospital stay, a more difficult operative procedure, and a higher rate of compensatory sweating than TS was. Reoperative sympathectomy should be considered a safe and effective option for patients with palmar hyperhidrosis who remain severely symptomatic after a sympathectomy.
| Introduction |
|---|
|
|
|---|
| Material and Methods |
|---|
|
|
|---|
|
|
Analysis of data was carried out using GraphPad Prism software 4.02 (San Diego, CA) for Windows (Microsoft, Redmond, WA). Continuous data are expressed as the mean ± SD of the mean except where otherwise indicated. Differences between categorical variables were evaluated by the Fisher's exact test. Differences between continuous variables were measured by the two-tailed Student t test. A value of p less than 0.05 was considered significant.
Operative Technique
General anesthesia was utilized for all subjects in this investigation. Neither central venous access nor intra-arterial blood pressure monitoring was performed. A single-lumen endotracheal tube was utilized and contralateral, single-lung ventilation established with the use of an Arndt bronchial blocker (Cook Medical, Bloomington, IN).
All patients were positioned in a semi-sitting position with the arms elevated above the head. The neck, chest, and abdomen were included in the operative field. Patients undergoing an initial thoracoscopic sympathectomy had a 5-mm thoracoscopic port placed in the anterior axillary line of the fifth intercostal space and the midclavicular line of the seventh intercostal space bilaterally after the skin and subcutaneous tissues had been infiltrated with local anesthetic. Mild CO2 insufflation was initiated. The 5-mm thoracoscope and a hook electrocautery instrument were used to incise the pleura overlying the sympathetic chain. The third thoracic sympathetic ganglion was then excised between the third and fourth ribs. A red rubber catheter was placed through the inferior port to the apex of the pleural space and placed to underwater seal. The lung was reexpanded. Once all air had been evacuated from the chest, the incisions were closed by approximating the skin with absorbable suture. If there was a persistent air leak from an injury to the visceral pleura, a 10F pleural catheter brought out through the most lateral port incision and was left in place for 12 to 14 hours. The procedure was then repeated on the contralateral side. Patients who did not require a pleural drain were discharged home the afternoon of surgery. Patients who required a pleural drain or failed to meet discharge criteria were admitted overnight and discharged the next morning.
Patients undergoing reoperative sympathectomy were similarly positioned and had the same initial port placements as described. Contralateral single lung ventilation and CO2 insufflation were also used. If there were extensive pleural adhesions, a third 5-mm port was placed to facilitate retraction of the lung. These patients also underwent the excision of the third thoracic sympathetic ganglion. The evacuation of pleural air, pleural drainage, and discharge intentions were the same as described for patients undergoing initial sympathectomy.
| Results |
|---|
|
|
|---|
|
|
A significant difference was also seen between the two patient groups related to length of stay. This was attributable exclusively to the placement of a pleural drain in reoperative patients. No patient in either group required longer than an overnight hospital stay after sympathectomy. There was not a mortality in either group of patients. There were no significant differences in the incidence of morbidity between the two groups (Table 5). No patient in either group required reoperation for bleeding or experienced a Horner's syndrome.
|
| Comment |
|---|
|
|
|---|
Endoscopic sympathectomy was not reported until 1951 by Kux [10]. He went on to develop a standardized technique for the procedure accomplished using intrathoracic insufflation without endotracheal intubation. However, despite the excellent results achieved by Kux [11] in a subsequent report of 55 patients with palmar and axillary hyperhidrosis, widespread interest and adoption of endoscopic sympathectomy awaited the advances in fiberoptic technologies and instrumentation that ushered in the modern era of endoscopic surgery.
Throughout the 1990s, the technique of endoscopic sympathectomy was enhanced until it had replaced all of the other techniques for thoracic sympathectomy for hyperhidrosis except one: percutaneous ablation. First reported in 1984 as a treatment for hyperhidrosis, this technique utilized radiofrequency ablation, thermal coagulation, or chemical ablation to destroy a segment of the sympathetic chain with or without image guidance [12]. Proponents of the procedure, often neurosurgeons, saw the ability to offer it to their patients without the need for general anesthesia or a thoracic surgical procedure. However, the lack of direct visualization of the sympathetic chain led to rates of recurrence of symptoms and Horner's syndrome that should be considered unacceptable when compared with the endoscopic technique in experienced hands [13].
As endoscopic sympathectomy and, to a lesser extent, percutaneous ablation have been used in increasing frequency over the last 20 years to treat primary palmar hyperhidrosis, some patients have not experienced an improvement in their symptoms. These patients can be segregated into those whose symptoms improved or completely resolve only to recur and those whose symptoms persisted after surgery. Rates of failure for endoscopic sympathectomy since 1999 have ranged between 1% and 4%, and persistence or recurrence of symptoms for percutaneous ablative techniques has been reported as high as 16% [13, 14].
While there is a paucity of literature describing the treatment of patients whose symptoms persist or recur after percutaneous ablative sympathectomy, four reports of reoperative endoscopic sympathectomy do exist. Orteu and colleagues [15] and Sing and coworkers [16] separately published case reports of patients who required reoperative sympathectomy for hyperhidrosis in 1995 and 1998, respectively. Hsu and coworkers [17] were the first to publish a series of patients requiring reoperative sympathectomy for palmar or axillary hyperhidrosis in 1998. All 20 of these patients had undergone previous endoscopic sympathectomy, with 19, or 95%, realizing relief of their symptoms after reoperation. The overwhelming reason for failure of the initial sympathectomy in these patients according to the authors was an inadequate or inaccurate initial sympathectomy.
Lin and colleagues [18] subsequently published what remains the largest series of patients undergoing reoperative sympathectomy for persistent or recurrent palmar hyperhidrosis. All of these patients had undergone an initial endoscopic sympathectomy. The authors reported that all patients in this series experienced resolution of their hyperhidrosis after reoperative sympathectomy but experienced an 86% incidence of compensatory sweating.
This investigation also demonstrates the effectiveness of reoperative sympathectomy for patients experiencing persistent or recurrent primary palmar hyperhidrosis after a previous sympathectomy. However, unlike the previously discussed reports, the methods of initial sympathectomy in this series were diverse and included axillary and posterior thoracotomies as well as a large number of patients who underwent percutaneous ablation. The results of reoperative sympathectomy in these patients have not been previously reported.
These different techniques produced varying degrees of pleural adhesions, which were not predictable based on the original form of sympathectomy and which accounted for the significant differences in pleural drainage and length of stay between the two patient groups. In fact, the authors observed some of the most dense and widespread adhesions in patients who had undergone a percutaneous ablation as their initial procedure (Fig 1). However, the technique of initial sympathectomy did result in technique specific reasons for failure. Inaccurate localization accounted for all of the failures of patients undergoing percutaneous ablation and alternative forms of thoracotomy, and incomplete resection of the sympathetic ganglion remained the common finding in patients who had previously undergone an endoscopic sympathectomy (Fig 2). These findings are intuitive, understanding that the percutaneous technique uses external landmarks to localize the area of the sympathetic chain, and that the two forms of thoracotomy used generally provide poor exposure to this area, especially on the right. Endoscopic sympathectomy provides excellent visualization of the sympathetic chain, with failures in these patients resulting almost exclusively failing to provide a complete form of sympathectomy.
|
|
Although this investigation reports the largest group of patients in the literature undergoing reoperative endoscopic sympathectomy after various initial procedures, some weaknesses do exist in its design. As in any unusual condition, the absolute number of patients in this study remains small. Also, although all patients included were considered to have failed medical therapy, patients were not randomly assigned to a nonsurgical treatment. The author's standard follow-up scheme was also utilized for all of the patients in this review. Rates of compensatory sweating in both patient groups and rates of recurrence in patients undergoing an initial sympathectomy might benefit from a longer period of postoperative observation.
In conclusion, this investigation found that, despite widely disparate techniques of initial sympathectomy for primary palmar hyperhidrosis, reoperative endoscopic sympathectomy is highly effective for patients who have persistent or recurrent symptoms. Reoperative sympathectomy is likely to encounter varying degrees of pleural adhesions, resulting in the increased need for postoperative pleural drainage and hospital admission. The incidence of significant compensatory sweating is also increased among patients undergoing reoperative sympathectomy. With these factors involved in the informed consent process, reoperative endoscopic sympathectomy should be offered by surgeons experienced in the technique to patients with severe persistent or recurrent symptoms of primary palmar hyperhidrosis after an unsuccessful sympathectomy, regardless of the initial technique used.
| Discussion |
|---|
|
|
|---|
This presentation describes a subgroup of patients rarely discussed in the thoracic literature, that is, patients who have suffered from a failed sympathectomy after either a previous thoracic surgical procedure or a previous percutaneous nerve ablation intervention. During this 6-year period, 40 patients of a total of almost 360 patients at their facility had surgery for repeat sympathectomy; 25 of these were for percutaneous ablation and 15 for prior sympathectomy. The authors have found that the redo sympathectomy was feasible with only minor additional morbidity, minor additional operating room time, and slightly longer duration of chest tube drainage. The success rates were the same among both groups, although the incidence of compensatory sweating was significantly worse in the redo group. I have three questions for Dr Freeman.
First, you note that the patients were assessed before and 2 months after sympathectomy. Our practice has been to follow up with patients either in person or by letter at least 2 more times during the postoperative period to assure that the patients complete their questionnaires at least one time during the summer season. Have you done this, or do you know the seasonal variation of your postoperative visits? Obviously, patients who are being followed up in Indiana in the wintertime may give better than average results.
Second, do you think that there is a difference between the two treatment groups, namely, those who had prior surgical sympathectomy versus those who had a percutaneous ablation? I know the numbers would be small, but have you had a chance to look at the subgroups and compare the differences in success rate among them?
Finally, one question regarding your technique. You describe the anesthesia technique as using a bronchial blocker. Does this mean that the patient was first bronchoscoped to place the blocker on one side and then rescoped to place the blocker on the other side, or did you just use the CO2 and only drop one lung? And then, again, on the surgical technique side, you describe excising the sympathetic ganglia. That is something that has rarely been described recently in the thoracic literature. Has your group tried in the past either cutting, ablating, or clipping the nerve above and below the ganglion rather than actually excising it?
Again, I want to thank the Association for the privilege of discussing the paper, and I congratulate you and your authors for a well-written manuscript and a well-presented series.
DR FREEMAN: Thank you, Dr Krasna. It is a pleasure to have you review our paper in light of your contributions to this subject, and I will answer your questions in order.
To be honest with you, we have not really considered when we do our follow-ups. In my practice, when I look at my office, these are the highest rate of no-show patients, both for new consultation and for follow-up, to the point that I have had to limit the number of these patients that I will see in one day because of the cancellations. We have a bimodal distribution, winter break, summer, because of the age of the patients. So most of the patients are operated on in the summer, and most of them still get their follow-up in the time when it is still warm, but that is a very good point.
Looking at the subpopulations, there is a very large difference in our small experience between patients who have had surgery and patients who had an ablation. The patients who had an ablation, they didn't get close to the sympathetic ganglion was the bottom line. So when we go in there, there are a lot of adhesions, you take that down, and then it is a straightforward surgery. The patients who had had prior surgical sympathectomy were a mixed bag; some had clips, some had the wrong ganglion worked on, et cetera, et cetera. So really, in the ablation patients, they just missed the sympathetic ganglia.
As far as the blocker, we use the bronchial blocker for almost all our procedures that we need, contralateral, single lung, ventilation, all except lung transplant, and have been very happy with it. The anesthesiologist places it on one side. We gently insufflate some CO2. As soon as we are done, they are repositioning the blocker while we are evacuating air before we move to the next side.
DR ROBERT J. CERFOLIO (Birmingham, AL): Congratulations. I think we have a unique opportunity here with all the experts in the room to answer some questions that I don't think we know the answer to. Now, you showed that 10 people had clips and failed. Is anybody in the room using clips routinely? Nobody. Clips only. Has anybody taken a clip off to treat compensatory hyperhidrosis, which is the reason people went to clips in the first place? Have you?
DR FREEMAN: No, I don't clip.
DR CERFOLIO: Does it work or is the nerve dead? So the advantage of the clip was to treat compensatory hyperhidrosis. I am unsure of the data that it does reverse compensatory hyperhidrosis, but I have heard personal reports from some that it does. Until we have data that it does, and since the failure rate may be higher with clipping instead of cutting the nerve, should we be clipping?
DR FREEMAN: Almost everybody in my office has been on the Internet and they say, do you clip?
DR CERFOLIO: Right, I get the same question, but can we get something out there now with data and all the world's experts here, or at least southern experts, that we should or shouldn't be clipping?
DR FREEMAN: In my opinion, yes, because if the hyperhidrosis goes away, it means the nerve is dead.
DR CERFOLIO: Right, I am agreeing with you, but I want to hear that from a group of experts.
DR KRASNA: Just a comment. There are no prospective randomized data in the literature that will show that clipping is better in any way than sympathectomy or sympathecotomy. I think what you have pointed out, though, is, for whatever reason, in your practice the majority of failures were among clips. But I don't know that we can say quite what you said yet, Cerf.
DR DANIEL L. MILLER (Atlanta, GA): Could you tell us briefly about the percutaneous ablation technique and the patients who failed treatment?
DR FREEMAN: The percutaneous patients who failed?
DR MILLER: No, the patients who had undergone a redo procedure. Why did they fail? Was it a wrong level? Did they miss the nerve? Was an accessory nerve still intact? More details would be greatly appreciated. Thank you.
DR FREEMAN: In general, there are three percutaneous techniques: thermal, radiofrequency, or chemical. There has been a large series reported from China, and in this country, neurosurgeons are very much a proponent of this because they can offer that and they can't offer the other thing. So I came after a neurosurgeon who did a bunch of these, and that is why we have those in our practice. They failed because they just didn't get to the right spot in our series. I don't have the denominator, so I can't tell you how many of them worked. But that is why they failed in our series.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |